And Abbott (ABT) is waiting for FDA approval of its drug-coated device which Boston Scientific (BSX) will also get to sell under a different brand name.
On Fast Money Huckman explains that at the conference, Merck (MRK) and Schering-Plough (SGP) are expected to present test results on their controversial drug, Vytorin.
Merck will also present data on weight-loss and heart drugs in its pipeline.
Also Bristol-Myers Squibb's (BMY) Plavix and Eli Lilly's (LLY) experimental blood thinner are in head-to-head study.
How can you trade it?
I think it’s all about Vytorin, says Pete Najarian. If doctors start using this drug Merck and Schering-Plough should profit. Also Merck has a cholesterol drug in its pipeline which could be big. But I like Lilly best, he says, for their diabetes drugs.
> Pharma’s Market with Mike Huckman
Got something to say? Send us an e-mail at firstname.lastname@example.org and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to email@example.com.
Trader disclosure: On Mar.27, 2008, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Macke Owns (YHOO), (DIS), (INTC); Finerman Owns (GS); Finerman's Firm Owns (DSW), (MSFT), (SUN), (TSO), (VLO), (WMT), (YHOO), (NYX), (PM-WI); Finerman's Firm Is Short (IYR), (IJR), (IWM), (MDY), (SPY); Najarian Owns (BKC), (MSFT), (NOK), (ORCL), (TSO), (XLF), (YHOO), (AAPL); Najarian Owns (AA) Calls, (CCU) Calls, (COP) Calls, (NVDA) Calls, (BSC) Calls, (CHK) Calls; Najarian Owns (LEH) Puts, (MER) Puts, (USB) Puts, (OIH) Puts; Seymour Owns (CFC), (F), (MER), (MSFT), (TMA), (AAPL), (TSO); Seygem Asset Management Owns (TSM); Charles Schwab Is A Sponsor Of "Fast Money"